{"pmid": "8964113", "sentences": {"sent_1": {"Section": "METHODS", "text": "Modulation of oxidant stress in vivo in chronic cigarette smokers .", "entities": {"entity_1": {"text": "oxidant stress", "class": "Outcome", "negation": 0, "UMLS": "", "start": 2}, "entity_2": {"text": "chronic cigarette smokers", "class": "Participant", "negation": 0, "UMLS": "", "start": 7}}, "relations": {}}, "sent_2": {"Section": "METHODS", "text": "BACKGROUND Free radical-induced oxidative damage is thought to be involved in the pathogenesis of diseases associated with cigarette smoking .", "entities": {}, "relations": {}}, "sent_3": {"Section": "METHODS", "text": "We examined the production of 8-epi-prostaglandin ( PG ) F2 alpha , a stable product of lipid peroxidation in vivo , and its modulation by aspirin and antioxidant vitamins in", "entities": {"entity_3": {"text": "production of 8-epi-prostaglandin ( PG ) F2 alpha", "class": "Outcome", "negation": 0, "UMLS": "", "start": 3}, "entity_4": {"text": "aspirin", "class": "Intervention", "negation": 0, "UMLS": "", "start": 25}, "entity_5": {"text": "antioxidant vitamins", "class": "Intervention", "negation": 0, "UMLS": "", "start": 27}}, "relations": {}}, "sent_4": {"Section": "METHODS", "text": "chronic cigarette smokers .", "entities": {"entity_6": {"text": "chronic cigarette smokers", "class": "Participant", "negation": 0, "UMLS": "", "start": 0}}, "relations": {}}, "sent_5": {"Section": "METHODS", "text": "METHODS AND RESULTS We performed the following studies : ( 1 ) a cross-sectional comparison of smokers and control subjects , ( 2 ) an examination of the dose-response relationship", "entities": {"entity_7": {"text": "smokers", "class": "Participant", "negation": 0, "UMLS": "", "start": 16}, "entity_8": {"text": "control", "class": "Intervention", "negation": 0, "UMLS": "", "start": 18}, "entity_9": {"text": "dose-response relationship", "class": "Outcome", "negation": 0, "UMLS": "", "start": 28}}, "relations": {}}, "sent_6": {"Section": "METHODS", "text": ", ( 3 ) an exploration of the effect of smoking cessation ( 3 weeks ) and nicotine patch supplementation , ( 4 ) the effect of aspirin consumption ,", "entities": {"entity_10": {"text": "smoking cessation", "class": "Intervention", "negation": 0, "UMLS": "", "start": 10}, "entity_11": {"text": "nicotine patch supplementation", "class": "Intervention", "negation": 0, "UMLS": "", "start": 17}, "entity_12": {"text": "aspirin consumption", "class": "Intervention", "negation": 0, "UMLS": "", "start": 27}}, "relations": {}}, "sent_7": {"Section": "METHODS", "text": "and ( 5 ) the effects of 5 days ' dosing with vitamin E ( 100 and 800 U ) , vitamin C ( 2 g ) , and their", "entities": {"attribute_1": {"text": "5 days ' dosing", "class": "measure", "negation": 0, "UMLS": "", "start": 7}, "entity_13": {"text": "vitamin E", "class": "Intervention", "negation": 0, "UMLS": "", "start": 12}, "attribute_2": {"text": "100 and 800 U", "class": "measure", "negation": 0, "UMLS": "", "start": 15}, "entity_14": {"text": "vitamin C", "class": "Intervention", "negation": 0, "UMLS": "", "start": 21}, "attribute_3": {"text": "2 g", "class": "measure", "negation": 0, "UMLS": "", "start": 24}}, "relations": {}}, "sent_8": {"Section": "METHODS", "text": "combination .", "entities": {}, "relations": {}}, "sent_9": {"Section": "METHODS", "text": "8-epi-PGF2 alpha excretion ( in pmol/mmol , mean +/- SEM ) was 176.5+/-30.6 in heavy smokers , 92.7+/-4.8 ( P < .05 ) in moderate smokers , and 54.1+/-2.7 (", "entities": {"entity_15": {"text": "8-epi-PGF2 alpha excretion", "class": "Outcome", "negation": 0, "UMLS": "", "start": 0}, "attribute_4": {"text": "heavy", "class": "measure", "negation": 0, "UMLS": "", "start": 14}, "entity_16": {"text": ", 92.7+/-4.8", "class": "Participant", "negation": 0, "UMLS": "", "start": 16}, "attribute_5": {"text": "P", "class": "measure", "negation": 0, "UMLS": "", "start": 19}, "attribute_6": {"text": ".05 ) in", "class": "measure", "negation": 0, "UMLS": "", "start": 21}, "entity_17": {"text": ", and", "class": "Participant", "negation": 0, "UMLS": "", "start": 26}}, "relations": {}}, "sent_10": {"Section": "METHODS", "text": "P < .005 ) in nonsmokers .", "entities": {"attribute_7": {"text": "P < .005", "class": "measure", "negation": 0, "UMLS": "", "start": 0}, "entity_18": {"text": "nonsmokers", "class": "Participant", "negation": 0, "UMLS": "", "start": 5}}, "relations": {}}, "sent_11": {"Section": "METHODS", "text": "Urinary levels fell from 145.5+/-24.9 to 114.6+/-27.1 ( week 2 , P < .05 ) and 112.6+/-24.9 ( week 3 , P < .05 ) on cessation of smoking .", "entities": {"entity_19": {"text": "Urinary levels", "class": "Outcome", "negation": 0, "UMLS": "", "start": 0}, "attribute_8": {"text": "fell", "class": "modifier", "negation": 0, "UMLS": "", "start": 2}, "attribute_9": {"text": "145.5+/-24.9 to 114.6+/-27.1", "class": "measure", "negation": 0, "UMLS": "", "start": 4}, "attribute_10": {"text": "P < .05", "class": "measure", "negation": 0, "UMLS": "", "start": 11}, "attribute_11": {"text": "112.6+/-24.9", "class": "measure", "negation": 0, "UMLS": "", "start": 16}, "attribute_12": {"text": "P < .05", "class": "measure", "negation": 0, "UMLS": "", "start": 21}, "entity_20": {"text": "cessation of smoking", "class": "Intervention", "negation": 0, "UMLS": "", "start": 26}}, "relations": {}}, "sent_12": {"Section": "METHODS", "text": "Aspirin treatment failed to suppress urinary levels of 8-epi-PGF2 alpha despite a significant reduction in urinary 11-dehydro-TxB2 production and suppression of 8-epi-PGF2 alpha and TxB2 in serum .", "entities": {"entity_21": {"text": "Aspirin", "class": "Intervention", "negation": 0, "UMLS": "", "start": 0}, "attribute_13": {"text": "suppress", "class": "modifier", "negation": 0, "UMLS": "", "start": 4}, "entity_22": {"text": "urinary levels of 8-epi-PGF2 alpha", "class": "Outcome", "negation": 0, "UMLS": "", "start": 5}, "attribute_14": {"text": "significant reduction", "class": "modifier", "negation": 0, "UMLS": "", "start": 12}, "entity_23": {"text": "urinary 11-dehydro-TxB2 production", "class": "Outcome", "negation": 0, "UMLS": "", "start": 15}, "attribute_15": {"text": "suppression", "class": "modifier", "negation": 0, "UMLS": "", "start": 19}, "entity_24": {"text": "8-epi-PGF2 alpha", "class": "Outcome", "negation": 0, "UMLS": "", "start": 21}, "entity_25": {"text": "TxB2", "class": "Outcome", "negation": 0, "UMLS": "", "start": 24}}, "relations": {}}, "sent_13": {"Section": "METHODS", "text": "Vitamin C ( pre , 194.6+/-40.9 ; post , 137.2+/-34.1 ; P < .05 ) and a combination of vitamin C and E ( pre , 171.0+/-39.8 ; post ,", "entities": {"entity_26": {"text": "Vitamin C", "class": "Intervention", "negation": 0, "UMLS": "", "start": 0}, "attribute_16": {"text": "194.6+/-40.9", "class": "measure", "negation": 0, "UMLS": "", "start": 5}, "attribute_17": {"text": "137.2+/-34.1", "class": "measure", "negation": 0, "UMLS": "", "start": 9}, "attribute_18": {"text": "P < .05", "class": "measure", "negation": 0, "UMLS": "", "start": 11}, "entity_27": {"text": "combination of vitamin C and E", "class": "Intervention", "negation": 0, "UMLS": "", "start": 17}, "attribute_19": {"text": "171.0+/-39.8", "class": "measure", "negation": 0, "UMLS": "", "start": 26}}, "relations": {}}, "sent_14": {"Section": "METHODS", "text": "133.5+/-29.6 P < .05 ) suppressed urinary 8-epi-PGF2 alpha , whereas vitamin E alone had no effect .", "entities": {"attribute_20": {"text": "133.5+/-29.6", "class": "measure", "negation": 0, "UMLS": "", "start": 0}, "attribute_21": {"text": "P < .05", "class": "measure", "negation": 0, "UMLS": "", "start": 1}, "attribute_22": {"text": "suppressed", "class": "modifier", "negation": 0, "UMLS": "", "start": 5}, "entity_28": {"text": "urinary 8-epi-PGF2 alpha", "class": "Outcome", "negation": 0, "UMLS": "", "start": 6}, "entity_29": {"text": "vitamin E", "class": "Intervention", "negation": 0, "UMLS": "", "start": 11}, "entity_30": {"text": "effect", "class": "Outcome", "negation": 0, "UMLS": "", "start": 16}}, "relations": {}}, "sent_15": {"Section": "METHODS", "text": "CONCLUSIONS Urinary 8-epi-PGF2 alpha may represent a noninvasive , quantitative index of oxidant stress in vivo .", "entities": {"entity_31": {"text": "Urinary 8-epi-PGF2 alpha", "class": "Outcome", "negation": 0, "UMLS": "", "start": 1}, "entity_32": {"text": "noninvasive , quantitative index of oxidant stress in vivo", "class": "Outcome", "negation": 0, "UMLS": "", "start": 7}}, "relations": {}}, "sent_16": {"Section": "METHODS", "text": "Elevated levels of 8-epi-PGF2 alpha in smokers may be modulated by quitting cigarettes and switching to nicotine patches or by antioxidant vitamin therapy .", "entities": {"attribute_23": {"text": "Elevated", "class": "modifier", "negation": 0, "UMLS": "", "start": 0}, "entity_33": {"text": "levels of 8-epi-PGF2 alpha", "class": "Outcome", "negation": 0, "UMLS": "", "start": 1}, "entity_34": {"text": "smokers", "class": "Intervention", "negation": 0, "UMLS": "", "start": 6}}, "relations": {}}}}